Literature DB >> 8737927

Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II--A review of histopathological aspects.

M L Maat-Schieman1, S G van Duinen, M Bornebroek, J Haan, R A Roos.   

Abstract

Cerebral amyloid-beta (A beta) angiopathy is the histopathological hallmark of hereditary cerebral hemorrhage with amyloidosis (Dutch) (HCHWA-D). A beta deposits are found mainly in the cerebral and cerebellar meningocortical blood vessels and as plaques throughout the cerebrocortical gray matter. A beta deposition in arteries and arterioles starts at the junction of media and adventitia and proceeds to involve the media causing degeneration of the vascular smooth muscle cells. Cerebrocortical arterioles often show one or two layers of radial A beta around a layer of homogenous A beta that replaces the media. Degenerating neurites, reactive astrocytes and microglial cells may surround cerebrocortical angiopathic arterioles and capillaries, probably in reaction to invasion of the perivascular neuropil by A beta fibrils. Furthermore, clusters of coarse extracellular matrix deposits may be found near A beta-laden cerebrocortical arterioles. The amyloid-associated proteins, cystatin C, and beta PP colocalize diffusely with Dutch vascular A beta, whereas HLA-DR immunoreactivity is found only in the periphery of the diseased vessel wall. The latter phenomenon may be related to the presence of perivascular cells. Angiopathic blood vessels frequently show structural changes. The relation of the described pathology to the development of hemorrhage, infarction and leukoencephalopathy needs further elucidation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737927     DOI: 10.1111/j.1750-3639.1996.tb00794.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  20 in total

1.  β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons.

Authors:  Alexandra M Nicholson; Lindsey A Wold; Dominic M Walsh; Adriana Ferreira
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

4.  Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.

Authors:  Maria E Conidi; Livia Bernardi; Gianfranco Puccio; Nicoletta Smirne; Maria G Muraca; Sabrina A M Curcio; Rosanna Colao; Paola Piscopo; Maura Gallo; Maria Anfossi; Francesca Frangipane; Alessandra Clodomiro; Maria Mirabelli; Franca Vasso; Chiara Cupidi; Giusi Torchia; Raffaele Di Lorenzo; Paola Mandich; Annamaria Confaloni; Raffaele G Maletta; Amalia C Bruni
Journal:  Neurology       Date:  2015-05-06       Impact factor: 9.910

5.  A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region.

Authors:  Jane M Olson; Katrina A B Goddard; Doreen M Dudek
Journal:  Am J Hum Genet       Date:  2002-05-15       Impact factor: 11.025

Review 6.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

Review 7.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

8.  β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.

Authors:  Ellis S van Etten; Marcel M Verbeek; Jeroen van der Grond; Ronald Zielman; Sanneke van Rooden; Erik W van Zwet; Anna M van Opstal; Joost Haan; Steven M Greenberg; Mark A van Buchem; Marieke J H Wermer; Gisela M Terwindt
Journal:  Neurology       Date:  2016-11-30       Impact factor: 9.910

Review 9.  Outcome markers for clinical trials in cerebral amyloid angiopathy.

Authors:  Steven M Greenberg; Rustam Al-Shahi Salman; Geert Jan Biessels; Mark van Buchem; Charlotte Cordonnier; Jin-Moo Lee; Joan Montaner; Julie A Schneider; Eric E Smith; Meike Vernooij; David J Werring
Journal:  Lancet Neurol       Date:  2014-02-27       Impact factor: 44.182

10.  Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy.

Authors:  Ellis S van Etten; M Edip Gurol; Jeroen van der Grond; Joost Haan; Anand Viswanathan; Kristin M Schwab; Alison M Ayres; Ale Algra; Jonathan Rosand; Mark A van Buchem; Gisela M Terwindt; Steven M Greenberg; Marieke J H Wermer
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.